Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 8.6
(0.35%)
CNY 8.6
(0.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 735.22 Million CNY | -12.51% |
| 2022 | 840.38 Million CNY | 9.33% |
| 2021 | 768.68 Million CNY | 31.26% |
| 2020 | 585.61 Million CNY | -4.12% |
| 2019 | 610.75 Million CNY | 11.34% |
| 2018 | 548.54 Million CNY | -0.1% |
| 2017 | 549.1 Million CNY | 6.03% |
| 2016 | 517.89 Million CNY | 18.73% |
| 2015 | 436.18 Million CNY | 17.13% |
| 2014 | 372.4 Million CNY | 16.25% |
| 2013 | 320.36 Million CNY | 27.36% |
| 2012 | 251.53 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 138.01 Million CNY | 0.8% |
| 2024 Q2 | 191.89 Million CNY | 39.04% |
| 2024 Q3 | 158.46 Million CNY | -17.42% |
| 2023 FY | 735.22 Million CNY | -12.51% |
| 2023 Q2 | 242.6 Million CNY | 48.86% |
| 2023 Q3 | 192.72 Million CNY | -20.56% |
| 2023 Q4 | 136.92 Million CNY | -28.96% |
| 2023 Q1 | 162.96 Million CNY | -1.08% |
| 2022 Q3 | 264.13 Million CNY | 23.59% |
| 2022 Q2 | 213.71 Million CNY | 8.05% |
| 2022 Q1 | 197.79 Million CNY | 11.7% |
| 2022 FY | 840.38 Million CNY | 9.33% |
| 2022 Q4 | 164.75 Million CNY | -37.63% |
| 2021 Q4 | 177.07 Million CNY | -23.34% |
| 2021 Q1 | 171.2 Million CNY | 6.08% |
| 2021 FY | 768.68 Million CNY | 31.26% |
| 2021 Q2 | 189.41 Million CNY | 10.64% |
| 2021 Q3 | 230.98 Million CNY | 21.95% |
| 2020 Q2 | 157.03 Million CNY | 100.78% |
| 2020 Q3 | 188.97 Million CNY | 20.34% |
| 2020 FY | 585.61 Million CNY | -4.12% |
| 2020 Q1 | 78.21 Million CNY | -46.16% |
| 2020 Q4 | 161.39 Million CNY | -14.6% |
| 2019 Q3 | 178.3 Million CNY | 12.33% |
| 2019 Q2 | 158.73 Million CNY | 23.56% |
| 2019 Q1 | 128.46 Million CNY | -5.74% |
| 2019 FY | 610.75 Million CNY | 11.34% |
| 2019 Q4 | 145.25 Million CNY | -18.53% |
| 2018 Q4 | 136.29 Million CNY | -15.07% |
| 2018 Q1 | 123.78 Million CNY | 0.64% |
| 2018 FY | 548.54 Million CNY | -0.1% |
| 2018 Q2 | 127.99 Million CNY | 3.4% |
| 2018 Q3 | 160.46 Million CNY | 25.37% |
| 2017 Q1 | 119.69 Million CNY | -3.31% |
| 2017 FY | 549.1 Million CNY | 6.03% |
| 2017 Q4 | 123 Million CNY | -23.78% |
| 2017 Q3 | 161.38 Million CNY | 11.28% |
| 2017 Q2 | 145.02 Million CNY | 21.16% |
| 2016 FY | 517.89 Million CNY | 18.73% |
| 2016 Q2 | 125.42 Million CNY | 8.5% |
| 2016 Q3 | 153.07 Million CNY | 22.05% |
| 2016 Q1 | 115.59 Million CNY | 1.45% |
| 2016 Q4 | 123.79 Million CNY | -19.13% |
| 2015 Q4 | 113.94 Million CNY | 0.0% |
| 2015 Q2 | 104.07 Million CNY | 0.0% |
| 2015 Q1 | 104.07 Million CNY | 1.33% |
| 2015 FY | 436.18 Million CNY | 17.13% |
| 2015 Q3 | 113.94 Million CNY | 9.48% |
| 2014 Q1 | 83.43 Million CNY | 0.0% |
| 2014 Q2 | 83.43 Million CNY | 0.0% |
| 2014 FY | 372.4 Million CNY | 16.25% |
| 2014 Q3 | 102.7 Million CNY | 23.1% |
| 2014 Q4 | 102.7 Million CNY | 0.0% |
| 2013 FY | 320.36 Million CNY | 27.36% |
| 2012 FY | 251.53 Million CNY | 0.0% |